Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe history shows a new revision v3.3.2 and removal of v3.2.0, indicating administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedNotice about government funding and operating status was removed from the page. This does not affect the study data, versions, or the history records of the trial.SummaryDifference0.7%

- Check37 days agoChange DetectedThe Record History shows updates to Study Status and Quality Control Review across versions, including new QC return notes and related status changes.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference12%

- Check73 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check87 days agoChange DetectedPage updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.